Researches

Faculty of Pharmacy

Assiut University

# Title Department Research Year
211 . Synthesis, Characterization and Photophysical Properties of Some New Thieno[2,3-b]pyridines bearing phenylethenyl moiety Department of Pharmaceutical Organic Chemistry 2021
212 A bio-analytically validated HPLC-UV method for simultaneous determination of doripenem and ertapenem in pharmaceutical dosage forms and human plasma: a dual carbapenem regimen for treatment of drug-resistant strain of Klebsiella pneumoniae Department of Pharmaceutical Analytical Chemistry 2021
213 Inversion Kinetics of Some E/Z 3-(Benzylidene)-2-Oxo-indoline Derivatives and Their In Silico CDK2 Docking Studies Department of Medicinal Chemistry 2021
214 FAK inhibitors as promising anticancer target: Present ‎and future directions Department of Pharmaceutical Organic Chemistry 2021
215 A novel fluorescent sensor for fast and highly selective turn-off detection of Fe3+ in water and pharmaceutical samples using synthesized azopyrazole-benzenesulfonamide derivative Department of Pharmaceutical Analytical Chemistry 2021
216 In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers Department of Industrial Pharmacy 2021
217 New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study Department of Pharmaceutical Organic Chemistry 2021
218 Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines Department of Pharmaceutics 2021
219 Mannitol capped magnetic dispersive micro-solid-phase extraction of polar drugs sparfloxacin and orbifloxacin from milk and water samples followed by selective fluorescence sensing using boron-doped carbon quantum dots Department of Pharmaceutical Analytical Chemistry 2021
220 Design, synthesis, biological assessment and in silico ADME prediction of new 2-(4- (methylsulfonyl) phenyl) benzimidazoles as selective cyclooxygenase-2 inhibitors 2021